- Corporate Officers - B
- Blaylock Ronald E
Insider Trading History of Blaylock Ronald E
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Blaylock Ronald E since 2005.
This trader's CIK number is 1214686.
At the time of last reporting, Blaylock Ronald E was the Director of Pfizer Inc. (stock ticker symbol PFE).
Also see all insider trading activities at Pfizer Inc.
Note that in the past
BLAYLOCK RONALD E also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Pfizer Inc (PFE) by Blaylock Ronald E
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2025 | PFE | 19,457 | $499,072 | 0 | $0 | 0 | $0 |
| 2020 | PFE | 13,000 | $501,410 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Carmax Inc (KMX) by Blaylock Ronald E
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2021 | KMX | 0 | $0 | 12,500 | $1,650,250 | 0 | $0 |
| 2020 | KMX | 0 | $0 | 10,200 | $911,574 | 0 | $0 |
| 2015 | KMX | 0 | $0 | 11,616 | $755,244 | 4,077 | $162,590 |
| 2013 | KMX | 700 | $29,680 | 0 | $0 | 0 | $0 |
| 2012 | KMX | 0 | $0 | 10,829 | $325,519 | 0 | $0 |
| 2011 | KMX | 0 | $0 | 8,110 | $243,381 | 8,110 | $140,205 |
| 2010 | KMX | 0 | $0 | 8,975 | $267,724 | 8,597 | $126,160 |
Yearly summary of insider trading at Berkley W R Corp (WRB) by Blaylock Ronald E
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2011 | WRB | 0 | $0 | 5,500 | $176,055 | 0 | $0 |
| 2010 | WRB | 0 | $0 | 2,000 | $53,924 | 0 | $0 |
| 2005 | WRB | 0 | $0 | 4,964 | $173,988 | 0 | $0 |
Yearly summary of insider trading at Urban One, Inc. (ROIA/ROIAK) by Blaylock Ronald E
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2015 | ROIA/ROIAK | 0 | $0 | 13,501 | $33,728 | 0 | $0 |
| 2008 | ROIA/ROIAK | 10,000 | $12,080 | 0 | $0 | 0 | $0 |
Insider trading activities at 4 companies by Blaylock Ronald E:
1. Pfizer Inc (PFE)
2. Carmax Inc (KMX)
3. Berkley W R Corp (WRB)
4. Urban One, Inc. (ROIA/ROIAK)
Table 1. Insider trading of Pfizer Inc (PFE) by Blaylock Ronald E
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2025-02-13 | PFE | Buy | 19,457 | 25.65 | 499,072 |
| 2020-08-06 | PFE | Buy | 13,000 | 38.57 | 501,410 |
Table 2. Insider trading of Carmax Inc (KMX) by Blaylock Ronald E
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2021-07-16 | KMX | Sale | 12,500 | 132.02 | 1,650,250 |
| 2020-07-13 | KMX | Sale | 10,200 | 89.37 | 911,574 |
| 2015-07-09 | KMX | Sale | 2,616 | 66.42 | 173,754 |
| 2015-07-09 | KMX | Option Ex | 4,077 | 39.88 | 162,590 |
| 2015-01-07 | KMX | Sale | 9,000 | 64.61 | 581,490 |
| 2013-04-16 | KMX | Buy | 700 | 42.40 | 29,680 |
| 2012-01-05 | KMX | Sale | 10,829 | 30.06 | 325,519 |
| 2011-12-23 | KMX | Sale | 8,110 | 30.01 | 243,381 |
| 2011-12-23 | KMX | Option Ex | 8,110 | 17.29 | 140,205 |
| 2010-10-26 | KMX | Sale | 8,975 | 29.83 | 267,724 |
| 2010-10-26 | KMX | Option Ex | 8,597 | 14.68 | 126,160 |
Table 3. Insider trading of Berkley W R Corp (WRB) by Blaylock Ronald E
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2011-04-27 | WRB | Sale | 5,500 | 32.01 | 176,055 |
| 2010-09-28 | WRB | Sale | 2,000 | 26.96 | 53,924 |
| 2005-06-09 | BER | Sale | 4,964 | 35.05 | 173,988 |
Table 4. Insider trading of Urban One, Inc. (ROIA/ROIAK) by Blaylock Ronald E
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2015-09-24 | ROIA/ROIAK | Sale | 10,000 | 2.45 | 24,500 |
| 2015-09-23 | ROIA/ROIAK | Sale | 2,100 | 2.60 | 5,460 |
| 2015-09-22 | ROIA/ROIAK | Sale | 1,401 | 2.69 | 3,768 |
| 2008-03-11 | ROIA/ROIAK | Buy | 10,000 | 1.21 | 12,080 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Blaylock Ronald E
(Director of Pfizer Inc at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.